Avai Bio (AVAI) Long-Term Investments (2018 - 2020)

Avai Bio has disclosed Long-Term Investments across 3 years of filings, most recently posting $55.0 for Q3 2020.

• In Q3 2020, Long-Term Investments changed N/A year-over-year to $55.0; the TTM figure through Sep 2020 stood at $55.0 (changed N/A YoY), while the FY2020 annual figure was $55.0, changed 0.0% from the prior year.
• Long-Term Investments came in at $55.0 for Q3 2020 at Avai Bio, roughly flat from $55.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $63995.0 in Q3 2018 to a low of $55.0 in Q1 2019.
• Average Long-Term Investments over 3 years is $11184.1, with a median of $577.5 recorded in 2019.
• The largest YoY upside for Long-Term Investments was 0.0% in 2020 against a maximum downside of 99.65% in 2020.
• Over 3 years, Long-Term Investments stood at $63995.0 in 2018, then sank by 98.28% to $1100.0 in 2019, then sank by 95.0% to $55.0 in 2020.
• Per Business Quant data, the three most recent Long-Term Investments figures were $55.0 in Q3 2020, $55.0 in Q2 2020, and $55.0 in Q1 2020.